SOLICITATION NOTICE
U -- Education and training services
- Notice Date
- 3/25/2009
- Notice Type
- Presolicitation
- NAICS
- 611699
— All Other Miscellaneous Schools and Instruction
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Heart, Lung and Blood Institute, Rockledge Dr. Bethesda, MD, Office of Acquisitions, 6701 Rockledge Dr RKL2/6100 MSC 7902, Bethesda, Maryland, 20892-7902
- ZIP Code
- 20892-7902
- Solicitation Number
- NHLBI-PB-(HG)-2009-108-DDC
- Archive Date
- 4/15/2009
- Point of Contact
- Deborah - Coulter,, Phone: (301) 435-0368
- E-Mail Address
-
dc143b@nih.gov
- Small Business Set-Aside
- N/A
- Description
- THIS IS A NOTICE OF INTENT, NOT A REQUEST FOR A PROPOSAL. A SOLICITATION DOCUMENT WILL NOT BE ISSUED AND PROPOSALS WILL NOT BE REQUESTED. It is the intent of the National Institutes of Health (NIH) National Heart, Lung and Blood Institute to procure the services for the National Human Genome Research Institute (NHGRI), Division of Intramural Research (DIR) from Quest Diagnostic Nicholas Institute for the following as outlined in the statement of work: Background: The National Human Genome Research Institute (NHGRI), Division of Intramural Research (DIR) was established to serve as a hub where development of technology for the rapid isolation and analysis of disease genes will be carried out. The DIR’s basic research laboratories and clinical branches develop and use the most advanced techniques to conduct research in medical genetics. Research includes identifying and understanding the molecular basis of human genetic disease and planning and carrying out clinical trials to test methods for the treatment. The mission of the DIR includes the training of physicians and doctoral degree fellows in medical genetics through the Metropolitan Washington, D.C. Medical Genetics Residency Program. The Metropolitan Washington, D.C. Medical Genetics Residency Program is administered by the Office of the Clinical Director (OCD) and is accredited by the American Board of Medical Genetics (ABMG). Requirement for board certification of competency of our trainees includes laboratory experiences in cytogenetics, biochemical genetics and molecular genetics. To meet these requirements the Medical Genetics Branch and OCD seek nearby institutions to provide these components of training for board certification in Clinical Genetics, Clinical Molecular Genetics, Clinical Biochemical Genetics and Cytogenetics, this institution or group of institutions must also provide the opportunity for trainees to see patients with genetic disorders under the direction of an ABMG board-certified geneticists. The cytogenetic laboratory experience of the trainees must include a routine karyotyping from peripheral blood in both children and adults, karyotyping of products of conception, prenatal diagnosis, cancer cytogenetics, and fluorescent in situ hybridization (FISH). The laboratory aspect of the training program will need to be conducted in cytogenetics diagnostic laboratories with equipment and personnel to provide the hands-on experience required for board certification by ABMB. The staff, which must include both ABMG board certified cytogenetics(s) and a genetic counselor, will be required to train fellows in applicable laboratory techniques and the clinical interpretation and implications of the test results. The staff must also participate in the comprehensive teaching of fellows; including participation in lecture series, journal clubs, and case conferences. A genetic counselor will assist in the training of fellows in the interpretation and genetic implication of tests they are learning to perform in these diagnostic laboratories. The cost of disposable supplies used by trainees will be included in the contract. The molecular genetic laboratory experience of the trainees must include a wide array of molecular diagnostic testing in the fields of neurodegenerative disorders, late onset disorders, imprinting disorders, mental retardation, neuromuscular disorders, and metabolic diseases, including prenatal diagnosis. The laboratory aspect of the training program will need to be conducted in molecular diagnostic laboratories with equipment and personnel to provide the hands-on experience required for board certification by ABMB. The staff, which must include ABMG board certified laboratory directors, will be required to train fellows in applicable laboratory techniques and the clinical interpretation and implications of the test results. The staff must also participate in the comprehensive teaching of fellows: including participation in lecture series, journal clubs, and case conferences. The cost of disposable supplies used by trainees will be included in the contract. This project is required for NHGRI/DIR to help provide the DIR with access to CLIA/CAO and ABMG approved settings to train fellows in the laboratory techniques of biomedical genetics and the genetic implications of test results from these diagnostic laboratories. The purpose of this contract is to maintain formal training program sites for the instruction of medical and doctoral fellows as part of the requirements for board certification in Clinical Biochemical Genetics, Clinical Genetics. The goals of the program are to: 1.Provide a training facility that will conduct one-month training experience in cytogenetics genetics for each of our Ph.D. Medical Genetics trainees seeking certification in Clinical Molecular Genetics, Clinical Biochemical Genetics and Clinical trainees. 2. Provide a training facility that will conduct up to six month training experiences in molecular genetic testing for common genetic conditions for each of our Ph.D. Medical Genetics trainees seeking certification in Clinical Molecular Genetics, Clinical Biochemical Genetics and Clinical Genetic trainees. 3. To provide a genetic counselor to assist in the training of the fellow in the genetic counseling implications of the diagnoses that have been made. 4. To participate in the comprehensive training of all trainees in genetics as part of the Metropolitan Washington, D.C. Medical Genetics Residency Program. The contractor shall perform the specific tasks: 1. Each year the training program will enroll up to four (4) clinical genetics fellows, two (2) clinical biochemical fellows, and three (3) clinical molecular genetics fellow. Each of these fellows will spend one (1) month each in the cytogenetics and molecular genetics laboratories. 2. Track the progress of each fellow to insure that they will have had necessary experiences for AMGB certification. Capability of Contractor Evaluation: The Contractor shall describe procedures needed to successfully train the fellows in required laboratory techniques and the genetic implications of the biochemical genetic tests. Facilities: The Contractor shall arrange to have suitable facilities, which include dedicated space for performance of administrative duties associated with tracking the progress of the medical fellows through the training. Quality Control: The Contractor shall establish and adhere to time lines for: 1. Providing all the required experiences for board certification with each month period. 2. Evaluate each medical fellow to insure they have a full understanding of all the techniques taught during training experiences. 3. Have sufficient samples submitted to the laboratory so that the fellows can have first-hand involvement in 150 cases of sufficient variety to qualify for ABMG Board eligibility. 4. Personnel qualifications are to be provided by the Contractor to the Project Officer for review and approval prior to the award of the contract. Required Reports/Deliverables: The Contractor shall prepare and deliver quarterly progress reports in the quantities specified to the recipients designated: Description of Reports: Quarterly Progress Report – A Quarterly Progress Report shall be submitted to the Project Officer within 30 calendar days after each three (3) month reporting period. This report shall include the following information: 1.Number of fellows instructed in biomedical genetics. 2.Number of fellows recommended repeating all or parts of the training sessions and why. 3.A narrative explaining any problems encountered that quarter, when they occurred and how they were resolved. The period of performance is April 1, 2009 through September 30, 2009. The sole source is based on the fact that Quest Diagnostic Inc., Nichols Institute provides training in the Cytogenetics and Common Molecular Genetics Diagnostic Testing. This training is a segment of the mandated curriculum of Washington, D.C. Metropolitan Genetics Fellowship Training Program required for Board certification in Clinical Genetics, Clinical Biochemical Genetics, Cytogenetics and /or Molecular Genetics. This training must be provided in CLIA approved, academic laboratories with expertise in this type of laboratory testing. Most of the tests are diagnostic for very rare disorder, and this particular laboratory meets the requirement of the American Board of Medical Genetics training criteria, which is it must be a 40-mile radius from the NIH campus to allow the Fellows to maintain their responsibilities at the NIH Clinical Center and train in this setting. The acquisition is being conducted under simplified acquisition procedures. The North American Industry Classification System (NAICS) is 651699 and Size Standard $7.0 Million is applicable to this requirement. The Small Business set-aside does not apply. This notice of intent is not a request for a competitive proposal. Interested parties may identify their interest and capabilities in response to this requirement. The determination by the Government not to compete the proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct future competitive procurement. Responses to this announcement, referencing synopsis number NHLBI-PB-(HG)-2009-108-DDC, may be submitted to the National Heart, Lung and Blood Institute, Office of Acquisition Center, Procurement Branch, Quotations must be submitted in writing to the National Heart, Lung and Blood Institute 6701 Rockledge Blvd., Room Suite 6100, Bethesda, Maryland 20892, Attention: Deborah Coulter, Emails will be accepted. All responsible sources may submit a quotation, which if timely received, shall be considered by the agency.
- Web Link
-
FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=70c26f36a79ea063cdf6a54d73dbc651&tab=core&_cview=1)
- Place of Performance
- Address: NIH, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN01777260-W 20090327/090325215653-70c26f36a79ea063cdf6a54d73dbc651 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |